Product Information

PHOSPHA 250 NEUTRAL TABLET is a generic product labeled by Rising Pharma Holdings Inc., priced at $0.2821 per EA under NDC 64980010401. Its NADAC has been published 652 times since Nov 28, 2013.

Strength

155; 852; 130 mg/1; mg/1; mg/1

NDC

64980010401

Classification

Generic

Dosage Form

TABLET

Route

ORAL

Last Updated

6/17/2026

Approval Type

Unapproved

On Market Since

6/28/2012

Price Statistics

The NADAC for PHOSPHA 250 NEUTRAL TABLET has been published 652 times since Nov 28, 2013, and over the history we have for it it has risen 100.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.2821 per EA
All-time high$0.3857 (Mar 16, 2016)
All-time low$0.1406 (Nov 28, 2013)
52-week high$0.2901
52-week low$0.1897
Median price$0.2449
Average price$0.2556
Largest weekly change+59.1% (Jan 22, 2014)
Weeks tracked652
Tracking sinceNov 28, 2013

Price History

1W

0.0%

1M

-2.7%

3M

+6.2%

6M

+17.4%

1Y

+45.6%

3Y

+34.7%

5Y

+2.0%

All

+100.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the Dibasic Sodium Phosphate, Monobasic Potassium Phosphate and Monobasic Sodium Phosphate market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of PHOSPHA 250 NEUTRAL TABLET?

The current National Average Drug Acquisition Cost (NADAC) for PHOSPHA 250 NEUTRAL TABLET, manufactured by Rising Pharma Holdings Inc., is $0.2821 per EA (NDC 64980010401), effective Jun 24, 2026.

How has the price of PHOSPHA 250 NEUTRAL TABLET changed over time?

Over the history we have for it, the NADAC for PHOSPHA 250 NEUTRAL TABLET has risen 100.6%. It has been tracked across 652 weekly CMS publications since Nov 28, 2013.

What are the highest and lowest recorded NADAC prices for PHOSPHA 250 NEUTRAL TABLET?

Since Nov 28, 2013, the NADAC for PHOSPHA 250 NEUTRAL TABLET has ranged from a low of $0.1406 (Nov 28, 2013) to a high of $0.3857 (Mar 16, 2016), with a median of $0.2449 per EA.

Are there cheaper alternatives to PHOSPHA 250 NEUTRAL TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of PHOSPHA 250 NEUTRAL TABLET, so no direct lower-cost alternative is listed.

Who manufactures PHOSPHA 250 NEUTRAL TABLET?

PHOSPHA 250 NEUTRAL TABLET (NDC 64980010401) is labeled by Rising Pharma Holdings Inc., and CMS classifies it as a generic product.

Related Drugs

Same classification

No related drugs found.